SCHEMBL25979846

SCHEMBL25979846

c1ccc(-c2ccc(-c3cc(-c4ccc5c(c4)oc4cc(N(c6ccccc6)c6ccc(-c7ccccc7)cc6)ccc45)nc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 10/20 0.43
KMT2A Q03164 10/20 0.43
ALDH1A1 P00352 8/20 0.43
HPGD P15428 8/20 0.43
MAPT P10636 7/20 0.43
NTSR1 P30989 1/20 0.43
KDM4E B2RXH2 5/20 0.42
LMNA P02545 2/20 0.42
GLA P06280 1/20 0.42
ADORA2A P29274 3/20 0.38
ADORA1 P30542 3/20 0.38
NPSR1 Q6W5P4 2/20 0.36
RXFP1 Q9HBX9 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
AURKA O14965 1/20 0.35
PDPK1 O15530 1/20 0.35
TGFBR1 P36897 1/20 0.35
AURKB Q96GD4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25979825 1.00 MEN1 (0.43) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25979844 1.00 MEN1 (0.43) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25979865 0.97 MEN1 (0.42) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL26779287 0.97 MEN1 (0.42) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL26415691 0.95 MEN1 (0.43) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25979365 0.94 MEN1 (0.40) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25979314 0.94 MEN1 (0.40) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25979316 0.94 MEN1 (0.40) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL26779157 0.94 MEN1 (0.40) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL25979869 0.93 CYP1A1 (0.46) MEN1KMT2AALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT MATERIALS CO., LTD. (KR) 2023-11-16 US disclosed
EP-4227301-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME LT Materials Co., Ltd. (KR) 2023-08-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365538-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, CYP1B1 MEN1 257/4885KMT2A 758/4885ALDH1A1 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.